Bevacizumab · ATC L01 · Oncology & immunology · Antineoplastic medicines
| # | Brand | Manufacturer | Strength | Form | Pack | Reg. no. | Official price | Unit price |
|---|---|---|---|---|---|---|---|---|
| 1 | ABEVMY | AGP Limited | 100 mg/4 mL | Concentrate for solution for infusion | 1's | 107907 | PKR 25,715.622026-07-23 | PKR 25,715.62/ vial/unit |
| 2 | Abevmy 400 | AGP Limited | 400 mg/16 mL (25 mg/mL) | Injection / infusion | 1's | 107908 | PKR 102,238.252026-07-23 | PKR 102,238.25/ vial/unit |
| 3 | Avastin | Roche Pakistan Ltd | 400 mg/16 mL | Concentrate for solution for infusion | 1's | 043005 | PKR 236,486.522026-07-29 | PKR 236,486.52/ vial/unit |
| 4 | BAZUMAB | Hilton Pharma (Pvt) Limited. | 100 mg/4 mL | IV infusion | 4mlx1's | 107941 | PKR 23,067.952025-07-01 | PKR 5,766.99/ mL |
| 5 | BAZUMAB | Hilton Pharma (Pvt) Limited. | 400 mg/16 mL | IV infusion | 16mlx1's | 107942 | PKR 91,711.792025-07-01 | PKR 5,731.99/ mL |
| 6 | Bevec | PHARMEVO (PVT) LTD. | 100 mg/4 mL (25 mg/mL) | Concentrate for infusion | 1's | 105569 | PKR 25,715.632026-07-23 | PKR 25,715.63/ vial/unit |
| 7 | Bevec | PHARMEVO (PVT) LTD. | 400 mg/16 mL (25 mg/mL) | Concentrate for solution for infusion | 1's | 105570 | PKR 102,238.252026-07-23 | PKR 102,238.25/ vial/unit |
| 8 | Cizumab | The Searle Company Limited | 400 mg/16 mL | Concentrate for solution for infusion | 1's | 105574 | PKR 132,267.992026-07-23 | PKR 132,267.99/ vial/unit |
| 9 | Cizumab EU | The Searle Company Limited | 100 mg/4 mL | Solution for infusion | 1's | 120492 | PKR 25,715.632026-07-23 | PKR 25,715.63/ vial/unit |
| 10 | Cizumab EU | The Searle Company Limited | 100 mg/4 mL (25 mg/mL) | Concentrate for infusion | 1's | 120492 | PKR 25,715.632026-07-23 | PKR 25,715.63/ vial/unit |
| 11 | Cizumab EU | The Searle Company Limited | 400 mg/16 mL | Solution for infusion | 1's | 120493 | PKR 102,238.252026-07-23 | PKR 102,238.25/ vial/unit |
| 12 | STIVANT | CCL Pharmaceuticals (Pvt.) Limited | 400 mg/16 mL | Concentrate for solution for infusion | 1's | 107906 | PKR 102,238.252026-07-23 | PKR 102,238.25/ vial/unit |
| 13 | Zirabev | Pfizer Pakistan Limited | 400 mg/16 mL (25 mg/mL) | Injection / infusion | 1's | 107970 | PKR 89,946.122026-07-27 | PKR 89,946.12/ vial/unit |
Live record: https://medinfobase.com/generic/bevacizumab/